Matthew Fisher

1.9k total citations
48 papers, 1.5k citations indexed

About

Matthew Fisher is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Matthew Fisher has authored 48 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Matthew Fisher's work include Angiogenesis and VEGF in Cancer (7 papers), Epigenetics and DNA Methylation (7 papers) and Blood properties and coagulation (5 papers). Matthew Fisher is often cited by papers focused on Angiogenesis and VEGF in Cancer (7 papers), Epigenetics and DNA Methylation (7 papers) and Blood properties and coagulation (5 papers). Matthew Fisher collaborates with scholars based in United States, United Kingdom and Canada. Matthew Fisher's co-authors include Miroslav Čolić, Richard L. Eckert, Gautam Adhikary, George V. Franks, Fred F. Lange, Daniel Grun, Wen Xu, Candace L. Kerr, Gillian M. Tozer and Jeffrey W. Keillor and has published in prestigious journals such as Journal of Clinical Investigation, Neuron and PLoS ONE.

In The Last Decade

Matthew Fisher

47 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Fisher United States 21 615 303 256 202 163 48 1.5k
Paul A. Reynolds United Kingdom 24 849 1.4× 260 0.9× 158 0.6× 359 1.8× 54 0.3× 59 1.7k
Joachim H. Clement Germany 32 1.5k 2.5× 463 1.5× 168 0.7× 98 0.5× 72 0.4× 103 3.2k
Jianhu Zhang China 28 565 0.9× 525 1.7× 152 0.6× 107 0.5× 103 0.6× 73 2.8k
Weiming Yu China 22 773 1.3× 101 0.3× 155 0.6× 76 0.4× 92 0.6× 88 2.1k
Yusuke Satoh Japan 29 886 1.4× 244 0.8× 72 0.3× 117 0.6× 331 2.0× 74 2.2k
Luxuan Guo China 19 693 1.1× 205 0.7× 127 0.5× 273 1.4× 459 2.8× 38 2.4k
Zhiwen Fan China 29 835 1.4× 170 0.6× 154 0.6× 105 0.5× 216 1.3× 83 2.0k
Mengzhe Wang United States 24 446 0.7× 262 0.9× 230 0.9× 78 0.4× 178 1.1× 73 1.8k
Jean‐François Stoltz France 25 430 0.7× 96 0.3× 171 0.7× 152 0.8× 82 0.5× 91 1.9k
Kyoko Shimizu Japan 25 722 1.2× 943 3.1× 200 0.8× 82 0.4× 188 1.2× 116 2.4k

Countries citing papers authored by Matthew Fisher

Since Specialization
Citations

This map shows the geographic impact of Matthew Fisher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Fisher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Fisher more than expected).

Fields of papers citing papers by Matthew Fisher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Fisher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Fisher. The network helps show where Matthew Fisher may publish in the future.

Co-authorship network of co-authors of Matthew Fisher

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Fisher. A scholar is included among the top collaborators of Matthew Fisher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Fisher. Matthew Fisher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fisher, Matthew, Mateus Crespo, Bora Gürel, et al.. (2024). Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy. Journal for ImmunoTherapy of Cancer. 12(7). e009368–e009368. 7 indexed citations
2.
Aa, Mironov, et al.. (2023). Rac1 controls cell turnover and reversibility of the involution process in postpartum mammary glands. PLoS Biology. 21(1). e3001583–e3001583. 3 indexed citations
3.
Fisher, Matthew, et al.. (2022). ΔNp63α in cancer: importance and therapeutic opportunities. Trends in Cell Biology. 33(4). 280–292. 12 indexed citations
4.
Fisher, Matthew, et al.. (2022). EZH2 regulates a SETDB1/ΔNp63α axis via RUNX3 to drive a cancer stem cell phenotype in squamous cell carcinoma. Oncogene. 41(35). 4130–4144. 11 indexed citations
5.
Fisher, Matthew, Yon Hwangbo, Caizhi Wu, et al.. (2021). BRD4 Regulates Transcription Factor ΔNp63α to Drive a Cancer Stem Cell Phenotype in Squamous Cell Carcinomas. Cancer Research. 81(24). 6246–6258. 14 indexed citations
6.
Fisher, Matthew, et al.. (2020). p63-related signaling at a glance. Journal of Cell Science. 133(17). 68 indexed citations
7.
Wang, Ying, et al.. (2019). NME1 Drives Expansion of Melanoma Cells with Enhanced Tumor Growth and Metastatic Properties. Molecular Cancer Research. 17(8). 1665–1674. 20 indexed citations
8.
English, William, Sarah Jane Lunt, Matthew Fisher, et al.. (2017). Differential Expression of VEGFA Isoforms Regulates Metastasis and Response to Anti-VEGFA Therapy in Sarcoma. Cancer Research. 77(10). 2633–2646. 28 indexed citations
9.
10.
Fisher, Matthew, et al.. (2017). Sulforaphane reduces YAP/∆Np63α signaling to reduce cancer stem cell survival and tumor formation. Oncotarget. 8(43). 73407–73418. 34 indexed citations
11.
Fisher, Matthew, et al.. (2017). Sulforaphane suppresses PRMT5/MEP50 function in epidermal squamous cell carcinoma leading to reduced tumor formation. Carcinogenesis. 38(8). 827–836. 19 indexed citations
12.
Kerr, Candace L., Henryk Szmacinski, Matthew Fisher, et al.. (2016). Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival. Oncogene. 36(21). 2981–2990. 53 indexed citations
13.
Brill, Monika S., Tatjana Kleele, Mengzhe Wang, et al.. (2016). Branch-Specific Microtubule Destabilization Mediates Axon Branch Loss during Neuromuscular Synapse Elimination. Neuron. 92(4). 845–856. 75 indexed citations
14.
Fisher, Matthew, Gautam Adhikary, Daniel Grun, David M. Kaetzel, & Richard L. Eckert. (2015). The Ezh2 polycomb group protein drives an aggressive phenotype in melanoma cancer stem cells and is a target of diet derived sulforaphane. Molecular Carcinogenesis. 55(12). 2024–2036. 50 indexed citations
15.
Fisher, Matthew, Jeffrey W. Keillor, Wen Xu, Richard L. Eckert, & Candace L. Kerr. (2015). Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival. Molecular Cancer Research. 13(7). 1083–1094. 50 indexed citations
16.
Adhikary, Gautam, Daniel Grun, Candace L. Kerr, et al.. (2013). Identification of a Population of Epidermal Squamous Cell Carcinoma Cells with Enhanced Potential for Tumor Formation. PLoS ONE. 8(12). e84324–e84324. 51 indexed citations
17.
Harris, Sheila, Madeleine L. Craze, Jillian Newton, et al.. (2012). Do Anti-Angiogenic VEGF (VEGFxxxb) Isoforms Exist? A Cautionary Tale. PLoS ONE. 7(5). e35231–e35231. 45 indexed citations
18.
Welford, Abigail, Daniela Biziato, Seth B. Coffelt, et al.. (2011). TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice. Journal of Clinical Investigation. 121(5). 1969–1973. 186 indexed citations
19.
Lunt, Sarah Jane, Simon Akerman, Sally A. Hill, et al.. (2010). Vascular effects dominate solid tumor response to treatment with combretastatin A‐4‐phosphate. International Journal of Cancer. 129(8). 1979–1989. 31 indexed citations
20.
Čolić, Miroslav, Matthew Fisher, & George V. Franks. (1998). Influence of Ion Size on Short-Range Repulsive Forces between Silica Surfaces. Langmuir. 14(21). 6107–6112. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul A. Reynolds Breakdown of academic impact, for papers by Joachim H. Clement Breakdown of academic impact, for papers by Jianhu Zhang Breakdown of academic impact, for papers by Weiming Yu Breakdown of academic impact, for papers by Yusuke Satoh Breakdown of academic impact, for papers by Luxuan Guo Breakdown of academic impact, for papers by Zhiwen Fan Breakdown of academic impact, for papers by Mengzhe Wang Breakdown of academic impact, for papers by Jean‐François Stoltz Breakdown of academic impact, for papers by Kyoko Shimizu
Rankless by CCL
2026